An Overview of the Biosimilar Market in the Us

Value in Health- United Kingdom

doi 10.1016/j.jval.2014.08.968

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

First Biosimilar Drug Set to Enter US Market

Nature
Multidisciplinary
2015English

An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2015English

Php316 - Exploring Biosimilar Market Access Considerations Across the Eu

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Market Liquidity Risk - An Overview

SSRN Electronic Journal
2009English

Non-Market Valuation in France. An Overview of the Research Activity Introduction

Revue d'Economie Politique
International RelationsPolitical Science
2015English

Immigrants in the US Labor Market

2014English

Integrated Power Market in West Africa: An Overview

Journal of Public Policy and Administration
2018English

An Overview and Critique of US Immigration and Asylum Policies in the Trump Era

Journal on Migration and Human Security
2019English

One Minute in the Life of the DM/US$: Public News in an Electronic Market

Journal of International Money and Finance
EconomicsEconometricsFinance
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy